Back to Search
MARK DEGEN, D.D.S., M.D.
D.D.S., M.D.
Oral and Maxillofacial Surgery (Dentist)
NPI: 1215002225Individual
Specialties, Licenses & Credentials
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
10535(NV)
Research & Publications (18)
The delineation of target volumes for radiotherapy of lung cancer patients.
PMID 19339069·Radiother Oncol·2009
8-other
Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblasts.
PMID 19309351·Clin Exp Allergy·2009
8-other
Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
PMID 19147558·Cancer Res·2009
8-other
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene.
PMID 18433484·BMC Cancer·2008
8-other
Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
PMID 18306355·Int J Cancer·2008
8-other
Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.
PMID 18298806·BMC Cancer·2008
4-observational
Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior.
PMID 17909022·Cancer Res·2007
8-other
Avian tenascin-W: expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro.
PMID 16534782·Dev Dyn·2006
7-preclinical
The effect of an early Le Fort III surgery on permanent molar eruption.
PMID 15692345·Plast Reconstr Surg·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4730 S FORT APACHE RD, STE 390
LAS VEGAS, NV 89147 - Phone
- (702) 253-9090
Quick Facts
- NPI
- 1215002225
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile